Taro Pharmaceutical Industries Ltd. EBITDA Margin 2010-2023 | TARO
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Taro Pharmaceutical Industries Ltd. (TARO) over the last 10 years. The current EBITDA margin for Taro Pharmaceutical Industries Ltd. as of December 31, 2023 is .
| EBITDA Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM EBITDA | EBITDA Margin |
| 2023-12-31 | $0.61B | $0.05B | 8.18% |
| 2023-09-30 | $0.59B | $0.04B | 6.58% |
| 2023-06-30 | $0.58B | $0.04B | 6.43% |
| 2023-03-31 | $0.57B | $0.06B | 10.12% |
| 2022-12-31 | $0.57B | $0.07B | 12.48% |
| 2022-09-30 | $0.57B | $0.11B | 19.86% |
| 2022-06-30 | $0.57B | $0.14B | 23.64% |
| 2022-03-31 | $0.56B | $0.10B | 18.36% |
| 2021-12-31 | $0.57B | $0.03B | 5.83% |
| 2021-09-30 | $0.57B | $0.02B | 4.23% |
| 2021-06-30 | $0.58B | $0.04B | 7.27% |
| 2021-03-31 | $0.55B | $-0.39B | -71.22% |
| 2020-12-31 | $0.58B | $-0.29B | -50.87% |
| 2020-09-30 | $0.58B | $-0.27B | -46.40% |
| 2020-06-30 | $0.60B | $-0.25B | -41.53% |
| 2020-03-31 | $0.65B | $0.27B | 41.55% |
| 2019-12-31 | $0.65B | $0.29B | 44.00% |
| 2019-09-30 | $0.68B | $0.31B | 45.13% |
| 2019-06-30 | $0.68B | $0.32B | 47.49% |
| 2019-03-31 | $0.67B | $0.31B | 46.87% |
| 2018-12-31 | $0.67B | $0.31B | 47.07% |
| 2018-09-30 | $0.64B | $0.30B | 45.81% |
| 2018-06-30 | $0.66B | $0.31B | 46.56% |
| 2018-03-31 | $0.66B | $0.32B | 48.26% |
| 2017-12-31 | $0.68B | $0.35B | 50.73% |
| 2017-09-30 | $0.75B | $0.41B | 55.29% |
| 2017-06-30 | $0.81B | $0.47B | 57.69% |
| 2017-03-31 | $0.88B | $0.53B | 60.30% |
| 2016-12-31 | $0.95B | $0.61B | 64.24% |
| 2016-09-30 | $0.99B | $0.65B | 66.23% |
| 2016-06-30 | $0.97B | $0.64B | 65.74% |
| 2016-03-31 | $0.95B | $0.63B | 66.21% |
| 2015-12-31 | $0.93B | $0.61B | 65.45% |
| 2015-09-30 | $0.91B | $0.59B | 65.35% |
| 2015-06-30 | $0.95B | $0.63B | 66.35% |
| 2015-03-31 | $0.86B | $0.54B | 62.92% |
| 2014-12-31 | $0.81B | $0.48B | 59.93% |
| 2014-09-30 | $0.78B | $0.46B | 58.70% |
| 2014-06-30 | $0.74B | $0.42B | 57.20% |
| 2014-03-31 | $0.76B | $0.45B | 58.89% |
| 2013-12-31 | $0.74B | $0.41B | 55.63% |
| 2013-09-30 | $0.71B | $0.38B | 53.60% |
| 2013-06-30 | $0.67B | $0.34B | 51.28% |
| 2013-03-31 | $0.67B | $0.35B | 51.71% |
| 2012-12-31 | $0.65B | $0.33B | 51.00% |
| 2012-09-30 | $0.61B | $0.30B | 49.43% |
| 2012-06-30 | $0.59B | $0.28B | 47.97% |
| 2012-03-31 | $0.54B | $0.24B | 44.75% |
| 2011-12-31 | $0.51B | $0.21B | 41.50% |
| 2011-09-30 | $0.46B | $0.15B | 33.48% |
| 2011-06-30 | $0.43B | $0.11B | 26.12% |
| 2011-03-31 | $0.41B | $0.10B | 23.36% |
| 2010-12-31 | $0.39B | $0.08B | 20.41% |
| 2010-09-30 | $0.38B | $0.08B | 20.27% |
| 2010-06-30 | $0.37B | $0.07B | 19.95% |
| 2010-03-31 | $0.37B | $0.07B | 20.27% |
